Superimposed Pre-Eclampsia
10
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
40%
4 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
Nudge to Drive Transitions of Care
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
The Effect of Foot Massage on Blood Pressure and Anxiety Levels in Pregnants With Hypertension
Postpartum NSAIDS and Maternal Hypertension
Phase I Study of Nicotinamide for Early Onset Preeclampsia
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial